We've found
2,431
archived clinical trials in
Back Pain
We've found
2,431
archived clinical trials in
Back Pain
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Updated: 12/31/1969
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials